Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.21.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2019 $ 46,125 $ 6,513,396 $ 138,024,957 $ (127,352,826) $ 17,231,652
Balance, shares at Dec. 31, 2019 46,124,803 16,017,113.941      
Compensation expense relating to option issuances 865,110 865,110
Series C dividend $ 661,458 (661,458)
Series C dividend, shares   19.542      
Net loss (5,187,760) (5,187,760)
Balance at Mar. 31, 2020 $ 46,125 $ 7,174,854 138,890,067 (133,202,044) 12,909,002
Ending balance, shares at Mar. 31, 2020 46,124,803 16,017,133.483      
Balance at Dec. 31, 2019 $ 46,125 $ 6,513,396 138,024,957 (127,352,826) 17,231,652
Balance, shares at Dec. 31, 2019 46,124,803 16,017,113.941      
Series C redemption        
Net loss         (17,525,056)
Balance at Jun. 30, 2020 $ 55,363 $ 7,174,854 147,097,173 (145,539,340) 8,788,050
Ending balance, shares at Jun. 30, 2020 55,362,803 16,017,133.483      
Balance at Mar. 31, 2020 $ 46,125 $ 7,174,854 138,890,067 (133,202,044) 12,909,002
Balance, shares at Mar. 31, 2020 46,124,803 16,017,133.483      
Compensation expense relating to option issuances 157,145 157,145
Issuance of common stock from warrant exercise $ 38 28,462 28,500
Issuance of common stock from warrant exercise, shares 38,000        
Issuance of common stock and warrants for the acquisition of Noachis = $ 9,200 8,021,499 8,030,699
Issuance of common stock and warrants for the acquisition of Noachis, shares 9,200,000        
Net loss (12,337,296) (12,337,296)
Balance at Jun. 30, 2020 $ 55,363 $ 7,174,854 147,097,173 (145,539,340) 8,788,050
Ending balance, shares at Jun. 30, 2020 55,362,803 16,017,133.483      
Balance at Dec. 31, 2020 $ 91,767 $ 7,174,854 164,022,957 (154,444,983) 16,844,595
Balance, shares at Dec. 31, 2020 91,766,928 16,017,133.483      
Compensation expense relating to option issuances 1,123,761 1,123,761
Series C dividend $ 1,117,531 (1,117,531)
Series C dividend, shares   33.016      
Series C redemption   $ (5,635,672)     (5,635,672)
Series C redemption, shares   (166.499)      
ATM offering - net of expenses $ 21,399 26,654,993 26,676,392
ATM offering - net of expenses, shares 21,398,765        
Issuance of common stock from warrant exercise $ 2,472 2,258,864 2,261,336
Issuance of common stock from warrant exercise, shares 2,472,573        
Net loss (5,219,945) (5,219,945)
Balance at Mar. 31, 2021 $ 115,638 $ 2,656,713 194,060,575 (160,782,459) 36,050,467
Ending balance, shares at Mar. 31, 2021 115,638,266 16,017,000      
Balance at Dec. 31, 2020 $ 91,767 $ 7,174,854 164,022,957 (154,444,983) 16,844,595
Balance, shares at Dec. 31, 2020 91,766,928 16,017,133.483      
Series C redemption         5,635,672
Net loss         (9,035,292)
Balance at Jun. 30, 2021 $ 116,195 $ 2,656,713 194,558,298 (164,597,806) 32,733,400
Ending balance, shares at Jun. 30, 2021 116,194,806 16,017,000      
Balance at Mar. 31, 2021 $ 115,638 $ 2,656,713 194,060,575 (160,782,459) 36,050,467
Balance, shares at Mar. 31, 2021 115,638,266 16,017,000      
Compensation expense relating to option issuances 231,140 231,140
Issuance of common stock from warrant exercise $ 557 266,583 267,140
Issuance of common stock from warrant exercise, shares 556,540        
Net loss (3,815,347) (3,815,347)
Balance at Jun. 30, 2021 $ 116,195 $ 2,656,713 $ 194,558,298 $ (164,597,806) $ 32,733,400
Ending balance, shares at Jun. 30, 2021 116,194,806 16,017,000